Nakagawa-machi, Japan
A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)
Phase
N/ASpan
105 weeksSponsor
Hoffmann-La RocheNeuburg
Recruiting
1-1 of 1